bioRxivMicrobiology
SARS-CoV-2 minor variant genomes at the start of the pandemic contained markers of VoCs
Abstract
SARS-CoV-2 emerged through limited zoonotic spillovers and was predicted to have constrained sequence diversity. The dominant consensus and minor variant genomes were determined from the earliest samples associated with the Huanan market and the start of the pandemic. The sequence data confirmed that the dominant consensus genomes shared very close homology. However, there were minor variant genomes present in each sample, which encompassed synonymous and non-synonymous changes. Fusion sequences characteristic of defective RNAs were identified that could be linked between patients. Several substitutions (but not deletions) associated with much later variants of concern (VoCs) were already present as minor variant genomes. This suggests it may be possible to predict futures variants at the start of a pandemic by examining where variability in sequence occurs.
- organism: human
- assay: whole-genome sequencing
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Limited SARS-CoV-2 diversity within hosts and following passage in cell culture
G. K. Moreno, K. M. Braun, … D. H. O'Connor·bioRxiv·Apr 20, 2020
- Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts
A. L. Valesano, K. E. Rumfelt, … A. S. Lauring·bioRxiv·Jan 19, 2021
- The rise and fall of SARS-CoV-2 variants and the emergence of competing Omicron lineages
T. R. Wiegand, A. McVey, … B. Wiedenheft·bioRxiv·Feb 9, 2022
- The rise and fall of SARS-CoV-2 variants and the mutational profile of Omicron
T. R. Wiegand, A. McVey, … B. Wiedenheft·bioRxiv·Dec 16, 2021
- Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.
T. Prince, X. Dong, … J. A. Hiscox·bioRxiv·Mar 30, 2021
- Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United States
Adrian A. Pater, Michael S. Bosmeny, … Keith T. Gagnon·bioRxiv·Jan 11, 2021